ProfileGDS4814 / ILMN_2145280
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 65% 68% 62% 65% 67% 66% 63% 67% 64% 65% 67% 66% 65% 67% 67% 69% 69% 69% 61% 67% 69% 67% 67% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)61.509765
GSM780708Untreated after 4 days (C2_1)67.688968
GSM780709Untreated after 4 days (C3_1)57.358262
GSM780719Untreated after 4 days (C1_2)61.455165
GSM780720Untreated after 4 days (C2_2)65.266767
GSM780721Untreated after 4 days (C3_2)62.561866
GSM780710Trastuzumab treated after 4 days (T1_1)58.118363
GSM780711Trastuzumab treated after 4 days (T2_1)64.829167
GSM780712Trastuzumab treated after 4 days (T3_1)60.057964
GSM780722Trastuzumab treated after 4 days (T1_2)60.603265
GSM780723Trastuzumab treated after 4 days (T2_2)64.7267
GSM780724Trastuzumab treated after 4 days (T3_2)63.39366
GSM780713Pertuzumab treated after 4 days (P1_1)61.122865
GSM780714Pertuzumab treated after 4 days (P2_1)64.686367
GSM780715Pertuzumab treated after 4 days (P3_1)64.994667
GSM780725Pertuzumab treated after 4 days (P1_2)70.454669
GSM780726Pertuzumab treated after 4 days (P2_2)70.454669
GSM780727Pertuzumab treated after 4 days (P3_2)70.809869
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)56.529761
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)64.338667
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)69.901669
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)64.254667
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)64.853267